Daily intake of antioxidants in relation to survival among adult patients diagnosed with malignant glioma

BMC Cancer

Volumn 10, Issue , 2010, Pages

  DeLorenze, Gerald N ^a   McCoy, Lucie ^b   Tsai, Ai Lin ^a   Quesenberry Jr, Charles P ^a   Rice, Terri ^b   Il'yasova, Dora ^c   Wrensch, Margaret ^b  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BIOCHANIN A; CALCIUM; CAROTENOID; CHOLESTEROL; COUMESTROL; CRYPTOXANTHIN; DAIDZEIN; FAT; FOLIC ACID; FORMONONETIN; GENISTEIN; LINOLEIC ACID; LYCOPENE; MATAIRESINOL; PROTEIN; SECOISOLARICIRESINOL; XANTHOPHYLL;

ADULT; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; GEOMETRY; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; INTERVIEW; MACRONUTRIENT; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL VALUE; POPULATION RESEARCH; SELF REPORT; BRAIN TUMOR; CANCER REGISTRY; CANCER STAGING; DATA BASE; DIET; GLIOMA; KAPLAN MEIER METHOD; MEDICAL RECORD; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; UNITED STATES;

ANTIOXIDANTS; BRAIN NEOPLASMS; CALIFORNIA; DATABASES AS TOPIC; DIET; DIET RECORDS; FEMALE; GLIOMA; HUMANS; INTERVIEWS AS TOPIC; KAPLAN-MEIERS ESTIMATE; LINEAR MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SEER PROGRAM; TIME FACTORS; TREATMENT OUTCOME;

EID: 77952293847     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-215     Document Type: Article

References (61)

1. Wrensch M, Rice T, Miike R, McMillan A, Lamborn KR, Aldape K, et al. Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area. Neuro Oncol 2006, 8:12-26. 10.1215/S1522851705000268, 1871921, 16443944.
2. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 2002, 4:278-299. 10.1215/15228517-4-4-278, 1920665, 12356358.
3. Davis FG, McCarthy BJ, Freels S, Kupelian V, Bondy ML. The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data. Cancer 1999, 85:485-491. 10.1002/(SICI)1097-0142(19990115)85:2<485::AID-CNCR29>3.0.CO;2-L, 10023719.
4. Nakamura M, Konishi N, Tsunoda S, Nakase H, Tsuzuki T, Aoki H, et al. Analysis of prognostic and survival factors related to treatment of low-grade astrocytomas in adults. Oncology 2000, 58:108-116. 10.1159/000012087, 10705237.
5. Kiwit JC, Floeth FW, Bock WJ. Survival in malignant glioma: analysis of prognostic factors with special regard to cytoreductive surgery. Zentralbl Neurochir 1996, 57:76-88.
6. Ramnarayan R, Dodd S, Das K, Heidecke V, Rainov NG. Overall survival in patients with malignant glioma may be significantly longer with tumors located in deep grey matter. J Neurol Sci 2007, 260:49-56. 10.1016/j.jns.2007.04.003, 17475281.
7. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998, 90:1473-1479. 10.1093/jnci/90.19.1473, 9776413.
8. Boulay JL, Miserez AR, Zweifel C, Sivasankaran B, Kana V, Ghaffari A, et al. Loss of NOTCH2 positively predicts survival in subgroups of human glial brain tumors. PLoS ONE 2007, 2:e576. 10.1371/journal.pone.0000576, 1892807, 17593975.
9. Ino Y, Zlatescu MC, Sasaki H, Macdonald DR, Stemmer-Rachamimov AO, Jhung S, et al. Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss. J Neurosurg 2000, 92:983-990. 10.3171/jns.2000.92.6.0983, 10839259.
10. Iwadate Y, Sakaida T, Hiwasa T, Nagai Y, Ishikura H, Takiguchi M, et al. Molecular classification and survival prediction in human gliomas based on proteome analysis. Cancer Res 2004, 64:2496-2501. 10.1158/0008-5472.CAN-03-1254, 15059904.
11. Lokker NA, Sullivan CM, Hollenbach SJ, Israel MA, Giese NA. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res 2002, 62:3729-3735.
12. Wrensch M, Wiencke JK, Wiemels J, Miike R, Patoka J, Moghadassi M, et al. Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res 2006, 66:4531-4541. 10.1158/0008-5472.CAN-05-4032, 16618782.
13. Wrensch M, Wiencke JK, Wiemels J, Miike R, Patoka J, Moghadassi M, et al. Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res 2006, 66:4531-4541. 10.1158/0008-5472.CAN-05-4032, 16618782.
14. Durmaz R, Vural M, Isildi E, Cosan E, Ozkara E, Bal C, et al. Efficacy of Prognostic Factors on Survival in Patients with Low Grade Glioma. Turk Neurosurg 2008, 18:336-344.
15. Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 2003, 99:467-473. 10.3171/jns.2003.99.3.0467, 12959431.
16. Bauman G, Lote K, Larson D, Stalpers L, Leighton C, Fisher B, et al. Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis. Int J Radiat Oncol Biol Phys 1999, 45:923-929.
17. Rainov NG, Dobberstein KU, Bahn H, Holzhausen HJ, Lautenschlager C, Heidecke V, et al. Prognostic factors in malignant glioma: influence of the overexpression of oncogene and tumor-suppressor gene products on survival. J Neurooncol 1997, 35:13-28. 10.1023/A:1005841520514, 9266437.
18. Murray KJ, Nelson DF, Scott C, Fischbach AJ, Porter A, Farnan N, et al. Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83-02. Int J Radiat Oncol Biol Phys 1995, 31:453-459.
19. Curran WJ, Scott CB, Weinstein AS, Martin LA, Nelson JS, Phillips TL, et al. Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02. J Clin Oncol 1993, 11:857-862.
20. Phuphanich S, Ferrall S, Greenberg H. Long-term survival in malignant glioma. Prognostic factors. J Fla Med Assoc 1993, 80:181-184.
21. Il'yasova D, Marcello JE, McCoy L, Rice T, Wrensch M. Total dietary antioxidant index and survival in patients with glioblastoma multiforme. Cancer Causes Control 2009, 20(8):1255-60. 10.1007/s10552-009-9338-7, 19363672.
22. Jarvela S, Bragge H, Paunu N, Jarvela T, Paljarvi L, Kalimo H, et al. Antioxidant enzymes in oligodendroglial brain tumors: association with proliferation, apoptotic activity and survival. J Neurooncol 2006, 77:131-140. 10.1007/s11060-006-9118-0, 16292483.
23. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002, 420:860-867. 10.1038/nature01322, 2803035, 12490959.
24. Stadtman ER, Levine RL. Protein oxidation. Ann N Y Acad Sci 2000, 899:191-208.
25. Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proc Natl Acad Sci USA 1995, 92:5258-5265. 10.1073/pnas.92.12.5258, 41674, 7777494.
26. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006, 160:1-40. 10.1016/j.cbi.2005.12.009, 16430879.
27. Aeder SE, Martin PM, Soh JW, Hussaini IM. PKC-eta mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways. Oncogene 2004, 23:9062-9069. 10.1038/sj.onc.1208093, 15489897.
28. da Rocha AB, Mans DR, Regner A, Schwartsmann G. Targeting protein kinase C: new therapeutic opportunities against high-grade malignant gliomas?. Oncologist 2002, 7:17-33. 10.1634/theoncologist.7-1-17, 11854544.
29. Martin V, Herrera F, Garcia-Santos G, Antolin I, Rodriguez-Blanco J, Rodriguez C. Signaling pathways involved in antioxidant control of glioma cell proliferation. Free Radic Biol Med 2007, 42:1715-1722. 10.1016/j.freeradbiomed.2007.02.028, 17462539.
30. Uht RM, Amos S, Martin PM, Riggan AE, Hussaini IM. The protein kinase C-eta isoform induces proliferation in glioblastoma cell lines through an ERK/Elk-1 pathway. Oncogene 2007, 26:2885-2893. 10.1038/sj.onc.1210090, 17146445.
31. Tanriverdi T, Hanimoglu H, Kacira T, Sanus GZ, Kemerdere R, Atukeren P, et al. Glutathione peroxidase, glutathione reductase and protein oxidation in patients with glioblastoma multiforme and transitional meningioma. J Cancer Res Clin Oncol 2007, 133:627-633. 10.1007/s00432-007-0212-2, 17457608.
32. Smith-Pearson PS, Kooshki M, Spitz DR, Poole LB, Zhao W, Robbins ME. Decreasing peroxiredoxin II expression decreases glutathione, alters cell cycle distribution, and sensitizes glioma cells to ionizing radiation and H(2)O(2). Free Radic Biol Med 2008, 45:1178-1189. 10.1016/j.freeradbiomed.2008.07.015, 2628750, 18718523.
33. Preuss M, Girnun GD, Darby CJ, Khoo N, Spector AA, Robbins ME. Role of antioxidant enzyme expression in the selective cytotoxic response of glioma cells to gamma-linolenic acid supplementation. Free Radic Biol Med 2000, 28:1143-1156. 10.1016/S0891-5849(00)00210-0, 10832077.
34. D'Archivio M, Santangelo C, Scazzocchio B, Vari R, Filesi C, Masella R, et al. Modulatory effects of polyphenols on apoptosis induction: relevance for cancer prevention. Int J Mol Sci 2008, 9:213-228. 10.3390/ijms9030213, 2635670, 19325744.
35. Khoshyomn S, Nathan D, Manske GC, Osler TM, Penar PL. Synergistic effect of genistein and BCNU on growth inhibition and cytotoxicity of glioblastoma cells. J Neurooncol 2002, 57:193-200. 10.1023/A:1015765616484, 12125982.
36. Pouliquen D, Olivier C, Hervouet E, Pedelaborde F, Debien E, Le Cabellec MT, et al. Dietary prevention of malignant glioma aggressiveness, implications in oxidant stress and apoptosis. Int J Cancer 2008, 123:288-295. 10.1002/ijc.23513, 18412241.
37. Galati G, O'Brien PJ. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radic Biol Med 2004, 37:287-303. 10.1016/j.freeradbiomed.2004.04.034, 15223063.
38. Meyer F, Bairati I, Fortin A, Gelinas M, Nabid A, Brochet F, et al. Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: a randomized trial among head and neck cancer patients. Int J Cancer 2008, 122:1679-1683. 10.1002/ijc.23200, 18059031.
39. Conklin KA. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Ther 2004, 3:294-300. 10.1177/1534735404270335, 15523100.
40. Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?. J Natl Cancer Inst 2008, 100:773-783. 10.1093/jnci/djn148, 18505970.
41. Wiemels JL, Wiencke JK, Sison JD, Miike R, McMillan A, Wrensch M. History of allergies among adults with glioma and controls. Int J Cancer 2002, 98:609-615. 10.1002/ijc.10239, 11920623.
42. Wrensch M, Lee M, Miike R, Newman B, Barger G, Davis R, et al. Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol 1997, 145:581-593.
43. Aldape K, Simmons ML, Davis RL, Miike R, Wiencke J, Barger G, et al. Discrepancies in diagnoses of neuroepithelial neoplasms: the San Francisco Bay Area Adult Glioma Study. Cancer 2000, 88:2342-2349. 10.1002/(SICI)1097-0142(20000515)88:10<2342::AID-CNCR19>3.0.CO;2-X, 10820357.
44. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993, 3:255-268. 10.1111/j.1750-3639.1993.tb00752.x, 8293185.
45. Lee M, Wrensch M, Miike R. Dietary and tobacco risk factors for adult onset glioma in the San Francisco Bay Area (California, USA). Cancer Causes Control 1997, 8:13-24. 10.1023/A:1018470802969, 9051318.
46. Tedeschi-Blok N, Lee M, Sison JD, Miike R, Wrensch M. Inverse association of antioxidant and phytoestrogen nutrient intake with adult glioma in the San Francisco Bay Area: a case-control study. BMC Cancer 2006, 6:148. 10.1186/1471-2407-6-148, 1513391, 16749939.
47. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986, 124:453-469.
48. Preston-Martin S, Mack W. Gliomas and meningiomas in men in Los Angeles County: investigation of exposures to N-nitroso compounds. IARC Sci Publ 1991, 197-203.
49. Rice-Evans CA, Miller NJ. Antioxidant activities of flavonoids as bioactive components of food. Biochem Soc Trans 1996, 24:790-795.
50. Cao G, Sofic E, Prior R. Antioxidant Capapcity of Tea and Common Vegetables. J Agric Food Chem 1996, 44:3426-3431.
51. Wang H, Cao G, Prior R. Total Antioxidant Capacity of Fruits. J Agric Food Chem 1996, 44:701-705.
52. Nordmann R. Oxidative stress from alcohol in the brain. Alcohol Alcohol Suppl 1987, 1:75-82.
53. Preston AM. Cigarette smoking-nutritional implications. Prog Food Nutr Sci 1991, 15:183-217.
54. Phuphanich S, Ferrall S, Greenberg H. Long-term survival in malignant glioma. Prognostic factors. J Fla Med Assoc 1993, 80:181-184.
55. Schindler R, Mentlein R. Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells. J Nutr 2006, 136:1477-1482.
56. Betti M, Minelli A, Canonico B, Castaldo P, Magi S, Aisa MC, et al. Antiproliferative effects of tocopherols (vitamin E) on murine glioma C6 cells: homologue-specific control of PKC/ERK and cyclin signaling. Free Radic Biol Med 2006, 41:464-472. 10.1016/j.freeradbiomed.2006.04.012, 16843827.
57. Al Delaimy WK, Ferrari P, Slimani N, Pala V, Johansson I, Nilsson S, et al. Plasma carotenoids as biomarkers of intake of fruits and vegetables: individual-level correlations in the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Clin Nutr 2005, 59:1387-1396. 10.1038/sj.ejcn.1602252, 16160702.
58. Hodge AM, Simpson JA, Fridman M, Rowley K, English DR, Giles GG, et al. Evaluation of an FFQ for assessment of antioxidant intake using plasma biomarkers in an ethnically diverse population. Public Health Nutr 2009, 12:2438-2447. 10.1017/S1368980009005539, 19371448.
59. Stupp R, Mason WP, Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352:987-996. 10.1056/NEJMoa043330, 15758009.
60. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990, 1:43-46.
61. Savitz DA. Interpreting Epidemiologic Evidence: Strategies for Study Design and Analysis 2003, New York: Oxford University Press.